These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3029427)

  • 21. Distinguishing cytomegalovirus, mycoplasma, and cellular DNA polymerases.
    Miller RL; Rapp F
    J Virol; 1976 Dec; 20(3):564-9. PubMed ID: 186634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical mapping of the human cytomegalovirus (HCMV) (Towne) DNA polymerase gene: DNA-mediated transfer of a genetic marker for an HCMV gene.
    D'Aquila RT; Hayward GS; Summers WC
    Virology; 1989 Jul; 171(1):312-6. PubMed ID: 2545037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
    Knopf CW
    J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phosphonoacetate-resistant mutant of herpesvirus of turkeys.
    Lee LF; Nazerian K; Witter RL; Leinbach SS; Boezi JA
    J Natl Cancer Inst; 1978 May; 60(5):1141-6. PubMed ID: 76681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of African swine fever (ASF virus replication by phosphonoacetic acid.
    Moreno MA; Carrascosa AL; Ortín J; Viñuela E
    J Gen Virol; 1978 May; 39(2):253-8. PubMed ID: 650176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a herpesvirus saimiri-specified DNA polymerase activity which is aphidicolin-resistant and phosphonoacetate-sensitive.
    O'Hare P; Honess RW
    J Gen Virol; 1983 May; 64(Pt 5):1013-24. PubMed ID: 6302206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antiherpesvirus action of phosphonoacetate.
    Boezi JA
    Pharmacol Ther; 1979; 4(1):231-43. PubMed ID: 88744
    [No Abstract]   [Full Text] [Related]  

  • 28. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    Snoeck R; Andrei G; De Clercq E
    Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the replication of herpes viruses by phosphonoacetate and related compounds.
    Newton AA
    Adv Ophthalmol; 1979; 38():267-75. PubMed ID: 230719
    [No Abstract]   [Full Text] [Related]  

  • 30. Human cytomegalovirus-associated DNA polymerase and protein kinase activities.
    Mar EC; Patel PC; Huang ES
    J Gen Virol; 1981 Nov; 57(Pt 1):149-56. PubMed ID: 6275014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity.
    Martin M; Azzi A; Lin SX; Boivin G
    Antivir Ther; 2010; 15(4):579-86. PubMed ID: 20587851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical mapping of paar mutations of herpes simplex virus type 1 and type 2 by intertypic marker rescue.
    Chartrand P; Stow ND; Timbury MC; Wilkie NM
    J Virol; 1979 Aug; 31(2):265-76. PubMed ID: 225553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphonoacetic acid-resistant mutants of herpes simplex virus: effect of phosphonoacetic acid on virus replication and in vitro deoxyribonucleic acid synthesis in isolated nuclei.
    Becker Y; Asher Y; Cohen Y; Weinberg-Zahlering E; Shlomai J
    Antimicrob Agents Chemother; 1977 May; 11(5):919-22. PubMed ID: 195514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional and molecular characterization of African swine fever virus mutants resistant to phosphonoacetic acid.
    Marques MI; Costa JV
    Virology; 1995 Dec; 214(1):72-81. PubMed ID: 8525640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of hepatitis-B-virus DNA polymerase by phosphonoformate: studies on its mode of action.
    Hess G; Arnold W; Meyer zum Büschenfelde KH
    J Med Virol; 1980; 5(4):309-16. PubMed ID: 6453206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic characterization of the vaccinia virus DNA polymerase: cytosine arabinoside resistance requires a variable lesion conferring phosphonoacetate resistance in conjunction with an invariant mutation localized to the 3'-5' exonuclease domain.
    Taddie JA; Traktman P
    J Virol; 1993 Jul; 67(7):4323-36. PubMed ID: 8389930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of eucaryotic DNA polymerases by phosphonoacetate and phosphonoformate.
    Sabourin CL; Reno JM; Boezi JA
    Arch Biochem Biophys; 1978 Apr; 187(1):96-101. PubMed ID: 655729
    [No Abstract]   [Full Text] [Related]  

  • 39. Herpes simplex virus resistance and sensitivity to phosphonoacetic acid.
    Honess RW; Watson DH
    J Virol; 1977 Feb; 21(2):584-600. PubMed ID: 189089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dissociation between cellular DNA- and histone synthesis following infection by cytomegalovirus in the presence of phosphonoacetic acid.
    Radsak K; Weder D
    Arch Virol; 1981; 68(3-4):313-20. PubMed ID: 6268023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.